Harnessing Liquid Biopsies to Guide Immune Checkpoint Inhibitor Therapy
Shadma Fatima(Camden and Campbelltown Hospitals), Paul de Souza(St. George Hospital), Kevin J. Spring(QIMR Berghofer Medical Research Institute), Kieran F. Scott(Ingham Institute), Tara L. Roberts(Camden and Campbelltown Hospitals), Therese M. Becker(Liverpool Hospital), Yafeng Ma(Camden and Campbelltown Hospitals), Azadeh Safrachi(UNSW Sydney), Fatemeh Vafaee(The University of Sydney), Sana Haider(Camden and Campbelltown Hospitals)
Cited by 17
Related Papers
Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
|New England Journal of Medicine|2012|2.8k
Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study
|The Lancet Oncology|2015|1.4k
HIN-200 Proteins Regulate Caspase Activation in Response to Foreign Cytoplasmic DNA
|Science|2009|822
AIM2 and NLRP3 inflammasomes activate both apoptotic and pyroptotic death pathways via ASC
|Cell Death and Differentiation|2013|507